FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095182049> ?p ?o ?g. }

• W3095182049 endingPage "28" @default.
• W3095182049 startingPage "28" @default.
• W3095182049 abstract "Chimeric receptor antigen (CAR)-T cell therapy using CARs specific for CD19 have been remarkably successful for treating chemo-refractory/relapsed B cell malignancies. These successes not withstanding, therapeutic outcomes between patients are variable and occasional cases of clonal expansion of the transduced T cells have been observed, albeit without leukemic transformation. These issues are cause for concern and need to be addressed to achieve better and safer therapeutic outcomes. Clonal expansion due to insertional mutagenesis and variegated transgene expression due to position effects are well established to be the consequence of the semi-random integration pattern afforded by gamma-retroviral and lentiviral vectors. We previously established that integration of a CAR cDNA in the TCR alpha locus (TRAC) provides consistent, regulated expression of CD19 CARs and superior CAR T cell efficacy in a mouse model of B-cell acute lymphoblastic leukemia (B-ALL). Here, we identify a novel extragenic site devoid of any known function and remote from endogenous genes, i.e. a 'genomic safe harbor' (GSH), that can be efficiently targeted in human T cells and drives potent CAR T cell therapy in the B-ALL mouse model. To identify GSHs that could be efficiently targeted in T cells by CRISPR-Cas9 and that could also support durable transgene expression, we screened for genomic regions meeting both, GSH criteria and high chromatin accessibility in T cells as measured by ATAC-seq. In human primary T cells, we identified 379 such sites. Ten of the highest accessible sites were investigated. All showed high (&gt;90%) cleavage efficiency and allowed for CAR cDNA targeted integration and expression which also translated into effective cytolytic activity of the CARs within a few days after transduction. However, thereafter CAR expression diminished over the course of a week at most but not all of these sites. In order to prevent possible heterochromatinization, we incorporated chromatin insulator elements with barrier activity flanking the CAR transcription unit. Incorporation of the chromatin insulator element dramatically improved CAR expression and functionality at one site, whereas 3 other GSHs tested were not affected. One of the 10 GSHs maintained long-term CAR expression without requiring an insulator and directed potent anti-leukemic CAR T cell efficacy in a B-ALL 'CAR stress test' mouse model, matching the T cell potency afforded by integrating the CAR cDNA at the TRAC locus. This finding highlights the major effect of the integration site on transgene expression and ensuing therapeutic efficacy. We identified an extragenic GSH site that can be used for effective T cell engineering and sustained expression of a CAR. Through this study, we provide a platform for identifying GSHs that could be reliably targeted for safe and predictable expression of CARs or other immunomodulatory transgenes to potentiate adoptive immunotherapy. Disclosures Sadelain: Fate Therapeutics: Patents & Royalties, Research Funding; Mnemo: Patents & Royalties; Atara: Patents & Royalties, Research Funding; Takeda: Patents & Royalties, Research Funding; Minerva: Other: Biotechnologies, Patents & Royalties." @default.
• W3095182049 created "2020-11-09" @default.
• W3095182049 creator A5009897724 @default.
• W3095182049 creator A5011606889 @default.
• W3095182049 creator A5040998041 @default.
• W3095182049 creator A5059625599 @default.
• W3095182049 creator A5085231879 @default.
• W3095182049 creator A5091271484 @default.
• W3095182049 creator A5091805400 @default.
• W3095182049 date "2020-11-05" @default.
• W3095182049 modified "2023-09-30" @default.
• W3095182049 title "Targeted Integration of a CAR at a Novel Genomic Safe Harbor Directs Potent Therapeutic Outcomes" @default.
• W3095182049 doi "https://doi.org/10.1182/blood-2020-141967" @default.
• W3095182049 hasPublicationYear "2020" @default.
• W3095182049 type Work @default.
• W3095182049 sameAs 3095182049 @default.
• W3095182049 citedByCount "1" @default.
• W3095182049 countsByYear W30951820492023 @default.
• W3095182049 crossrefType "journal-article" @default.
• W3095182049 hasAuthorship W3095182049A5009897724 @default.
• W3095182049 hasAuthorship W3095182049A5011606889 @default.
• W3095182049 hasAuthorship W3095182049A5040998041 @default.
• W3095182049 hasAuthorship W3095182049A5059625599 @default.
• W3095182049 hasAuthorship W3095182049A5085231879 @default.
• W3095182049 hasAuthorship W3095182049A5091271484 @default.
• W3095182049 hasAuthorship W3095182049A5091805400 @default.
• W3095182049 hasBestOaLocation W30951820491 @default.
• W3095182049 hasConcept C102230213 @default.
• W3095182049 hasConcept C104317684 @default.
• W3095182049 hasConcept C107635520 @default.
• W3095182049 hasConcept C141231307 @default.
• W3095182049 hasConcept C147483822 @default.
• W3095182049 hasConcept C19317047 @default.
• W3095182049 hasConcept C2776090121 @default.
• W3095182049 hasConcept C2778957590 @default.
• W3095182049 hasConcept C3875195 @default.
• W3095182049 hasConcept C502942594 @default.
• W3095182049 hasConcept C54355233 @default.
• W3095182049 hasConcept C70721500 @default.
• W3095182049 hasConcept C86803240 @default.
• W3095182049 hasConcept C8891405 @default.
• W3095182049 hasConceptScore W3095182049C102230213 @default.
• W3095182049 hasConceptScore W3095182049C104317684 @default.
• W3095182049 hasConceptScore W3095182049C107635520 @default.
• W3095182049 hasConceptScore W3095182049C141231307 @default.
• W3095182049 hasConceptScore W3095182049C147483822 @default.
• W3095182049 hasConceptScore W3095182049C19317047 @default.
• W3095182049 hasConceptScore W3095182049C2776090121 @default.
• W3095182049 hasConceptScore W3095182049C2778957590 @default.
• W3095182049 hasConceptScore W3095182049C3875195 @default.
• W3095182049 hasConceptScore W3095182049C502942594 @default.
• W3095182049 hasConceptScore W3095182049C54355233 @default.
• W3095182049 hasConceptScore W3095182049C70721500 @default.
• W3095182049 hasConceptScore W3095182049C86803240 @default.
• W3095182049 hasConceptScore W3095182049C8891405 @default.
• W3095182049 hasIssue "Supplement 1" @default.
• W3095182049 hasLocation W30951820491 @default.
• W3095182049 hasOpenAccess W3095182049 @default.
• W3095182049 hasPrimaryLocation W30951820491 @default.
• W3095182049 hasRelatedWork W1848958118 @default.
• W3095182049 hasRelatedWork W2008086904 @default.
• W3095182049 hasRelatedWork W2885832251 @default.
• W3095182049 hasRelatedWork W2972102845 @default.
• W3095182049 hasRelatedWork W3003314604 @default.
• W3095182049 hasRelatedWork W3193547326 @default.
• W3095182049 hasRelatedWork W3215836775 @default.
• W3095182049 hasRelatedWork W4251655028 @default.
• W3095182049 hasRelatedWork W4283333352 @default.
• W3095182049 hasRelatedWork W4318616170 @default.
• W3095182049 hasVolume "136" @default.
• W3095182049 isParatext "false" @default.
• W3095182049 isRetracted "false" @default.
• W3095182049 magId "3095182049" @default.
• W3095182049 workType "article" @default.